BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, July 20, 2025
See today's BioWorld
Home
» Zealand Pharma fishes Encycle from bargain bin in $80M back-loaded deal
To read the full story,
subscribe
or
sign in
.
Zealand Pharma fishes Encycle from bargain bin in $80M back-loaded deal
Oct. 23, 2019
By
Cormac Sheridan
DUBLIN –
Zealand Pharma A/S
has up to now generated its pipeline of peptide drugs internally, but it has gone hunting in biotech's bargain bin to find its first externally sourced asset.
BioWorld
Deals and M&A
